Giulio Muccioli (born in 1978)[1] is a pharmacologist and bioanalyst who is professor and director of research at the University of Louvain (Belgium).[2] He is recognized as a world expert in endocannabinoid receptors.[3] His research is focused on the roles of bioactive lipids both in physiological and pathological situations, mainly related to inflammation.[4]
Giulio Muccioli | |
|---|---|
| Born | 1978 |
| Other names | Giulio G. Muccioli (in publications) |
| Alma mater | University of Louvain (Belgium) |
| Known for | Endocannabinoid receptors research |
| Scientific career | |
| Fields | Pharmacology, Bioanalysis |
| Institutions | University of Louvain (Belgium) |
| Thesis | Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as modulators of the endocannabinoid system (2005) |
| Doctoral advisor | Prof. Didier Lambert |
Education edit
Giulio Muccioli studied pharmacy at the University of Louvain.[2] He graduated in 2001 and pursued doctoral studies in pharmaceutical sciences, focusing on synthesis and pharmacological evaluation of compounds interacting with the endocannabinoid system. He obtained his Ph.D. in 2005 under the guidance of Prof. Didier Lambert.[2][5] After that, he completed from 2005 to 2007 a Post-Doctoral Fellowship in the laboratory of Prof. Nephi Stella at the University of Washington (Seattle, USA), specialized in Cannabinoid Pharmacology [6]
Career edit
Giulio Muccioli returned to the University of Louvain, first as an F.R.S.-FNRS Research Fellow (2007–2008). Since 2008 he has been Professor in the Faculty of Pharmacy and Biomedical Sciences.[7]
He created a research group, the Bioanalysis and Pharmacology of Bioactive Lipids (BPBL), within the Louvain Drug Research Institute (LDRI), which he currently leads.[8] His research interests encompass the roles of bioactive lipids both in physiological mechanisms and pathological situations, mainly related to inflammation and related diseases, such as obesity, multiple sclerosis, inflammatory bowel disease or cancer.[1][4]
In 2016, he became President of The School of Pharmacy (University of Louvain),[1][9] and vice president of the Louvain Drug Research Institute.[1]
Muccioli is also member of the Pharmacopoeia Commission of the Belgian Federal Agency for Medecines and Health Products (FAMHP).[10][11]
In 2018, Giulio Muccioli became with the BPBL research group co-organizer of the European Workshop on Lipid Mediators.[12][13]
Awards edit
In 2016, Giulio Muccioli received a research award from the Belgian Charcot Foundation for his project to study the effect of NAAA inhibition on the course of experimental autoimmune encephalitis in mice.[14]
In 2018, Giulio Muccioli won the Eugène De Somer Award for upstanding work in fundamental research in the biomedical sciences field.[3]
Publications edit
Muccioli has published over 150 articles in peer-reviewed journals throughout his thesis and career.[2][15]
References edit
- ^ a b c d "Des lipides bioactifs au cœur de l'inflammation". UCLouvain. Retrieved May 24, 2020.
- ^ a b c d "UCLouvain – Giulio Muccioli". UCLouvain. Retrieved May 23, 2020.
- ^ a b "UCLouvain – Remise prix et bourses 2018" (PDF). Louvainmedical. Retrieved May 23, 2020.
- ^ a b "Bioanalysis and Pharmacology of Bioactive Lipids - In brief". UCLouvain. Retrieved May 23, 2020.
- ^ "Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as modulators of the endocannabinoid system / Giulio Muccioli; promoteur : Didier Lambert". UCLouvain. Retrieved May 23, 2020.
- ^ "Stella Lab Home". depts.washington.edu. Retrieved May 23, 2020.
- ^ "Biologically active γ-lactams: synthesis and natural sources". UCLouvain. Retrieved May 23, 2020.
- ^ "Bioanalysis and Pharmacology of Bioactive Lipids". UCLouvain. Retrieved May 23, 2020.
- ^ "FASB - Organisation". UCLouvain. Retrieved May 23, 2020.
- ^ "Commission pour les médicaments à base de plantes à usage humain". FAMHP. Retrieved May 23, 2020.
- ^ "Commission de la Pharmacopée". FAMHP. Retrieved May 23, 2020.
- ^ "The "7th European Workshop on Lipid Mediators", co-organized by the BPBL research group (Prof Muccioli and Dr Alhouayek), will be held at the UCL in Brussels from 12-14 September 2018". UCLouvain. Retrieved May 24, 2020.
- ^ "8th European Workshop on Lipid Mediators". European Workshop on Lipid Mediators. Retrieved May 24, 2020.
- ^ "Fighting MS Through Research". Fondation Charcot. Retrieved May 23, 2020.
- ^ "Bibliography - Giulio Muccioli". UCLouvain. Retrieved May 23, 2020.